Soluble FcγRIIIaMφ levels in plasma correlate with carotid maximum intima-media thickness (IMT) in subjects undergoing an annual medical checkup

Molecular Medicine

Volumn 14, Issue 7-8, 2008, Pages 436-442

  Masuda, Midori ^a   Amano, Katsuya ^a   Shi, Yan Hong ^a   Nishimura, Noriko ^a   Fukui, Masayoshi ^a   Yoshika, Masamichi ^a   Komiyama, Yutaka ^a   Masaki, Hiroya ^a   Iwasaka, Toshiji ^a   Takahashi, Hakuo ^a  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD16 ANTIGEN; CREATININE; FC GAMMA RECEPTOR IIIA; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; FC RECEPTOR; FCGR3A PROTEIN, HUMAN;

ADULT; AGE; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD CHEMISTRY; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY; CORONARY ARTERY ATHEROSCLEROSIS; CORRELATION ANALYSIS; CREATININE BLOOD LEVEL; DIABETES MELLITUS; FAMILY HISTORY; FEMALE; HEMOGLOBIN BLOOD LEVEL; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERTENSION; HYPOCHOLESTEROLEMIA; INTIMA; MACROPHAGE; MACROPHAGE ACTIVATION; MAJOR CLINICAL STUDY; MALE; MEDICAL EXAMINATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TRIACYLGLYCEROL BLOOD LEVEL; TUNICA MEDIA; BIOLOGICAL MODEL; BLOOD; CAROTID ARTERY; HISTOLOGY; MIDDLE AGED; PHYSICAL EXAMINATION; PROGNOSIS; SOLUBILITY;

ADULT; ATHEROSCLEROSIS; CAROTID ARTERIES; FEMALE; HUMANS; MALE; MIDDLE AGED; MODELS, BIOLOGICAL; PHYSICAL EXAMINATION; PROGNOSIS; RECEPTORS, IGG; SOLUBILITY; TUNICA INTIMA;

EID: 48149109849     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/2007-00113.Masuda     Document Type: Article

References (23)

1. Ravetch JV, Perussia BV. (1989) Alternative membrane forms of Fc gamma RIII (CD16) on human natural killer cells and neutrophils. Cell type-specific expression of two genes that differ in single nucleotide substitutions. J. Exp. Med. 170:481-97.
2. de Haas M, Kleijer M, Minchinton RM, Roos D, von dem Borne AE. (1994) Soluble Fc gamma RIIIa is present in plasma and is derived from natural killer cells. J. Immunol. 152:900-7.
3. Huizinga TW, Kleijer M, Tetteroo PA, Roos D, von dem Borne AE. (1990) Biallelic neutrophil NA-antigen system is associated with a polymorphism on the phospho-inositol-linked Fcγ receptor III (CD16). Blood. 75:213-7.
4. Harrison D, Phillips JH, Lanier LL. (1991) Involvement of a metalloprotease in spontaneous and phorbol ester-induced release of natural killer cell-associated Fc gamma RIII (CD16-II). J. Immunol. 147:3459-65.
5. Levy PC et al. (1991) Characterization of human alveolar macrophage Fc gamma receptor III: A transmembrane glycoprotein that is shed under in vitro culture conditions. Am. J. Respir. Cell Mol. Biol. 5:307-14.
6. Huizinga TW et al. (1994) The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils. Br. J. Haematol. 87:459-63.
7. Homburg CHE et al. (1995) Human neutrophils lose their surface Fc gamma RIII and acquire Annexin V binding sites during apoptosis in vitro. Blood. 85:532-40.
8. Middelhoven PJ, van Buul JD, Hordijk PL, Roos D. (2001) Different proteolytic mechanisms involved in Fc gamma RIIIb shedding from human neutrophils. Clin. Exp. Immunol. 125:169-75.
9. Ross R. (1995) Cell biology of atherosclerosis. Annu. Rev. Physiol. 57:791-804.
10. van der Wal AC, Das PK, Tigges AJ, Becker AE. (1992) Macrophage differentiation in atherosclerosis. An in situ immunohistochemical analysis in humans. Am. J. Pathol. 141:161-8.
11. Rothe G et al. (1996) Peripheral blood mononuclear phagocyte subpopulations as cellular markers in hypercholesterolemia. Arterioscler. Thromb. Vasc. Biol. 16:1437-47.
12. Ratcliffe NR, Kennedy SM, Morganelli PM. (2001) Immunocytochemical detection of Fcgamma receptors in human atherosclerotic lesions. Immunol. Letters. 77:169-74.
13. Kiener PA et al. (1995) Immune complexes of LDL induce atherogenic responses in human monocytic cells. Arterioscler. Thromb Vasc. Biol. 15:990-9.
14. Dollery CM, McEwan JR, Henney AM. (1995) Matrix metalloproteinases and cardiovascular disease. Circ. Res. 77:863-8.
15. Masuda M et al. (2003) Measurement of soluble Fcgamma receptor type IIIa derived from macrophages in plasma: increase in patients with rheumatoid arthritis. Clin. Exp. Immunol. 132:477-84.
16. Masuda M et al. (2006) Increased soluble FcgammaRIIIa (Mphi) in plasma from patients with coronary artery diseases. Atherosclerosis. 188: 377-83.
17. Koene HR, de Haas M, Kleijer M, Roos D, von dem Borne AE. (1996) NA-phenotype-dependent differences in neutrophil Fc gamma RIIIb expression cause differences in plasma levels of soluble Fc gamma RIII. Br. J. Haematol. 93:235-41.
18. Handa N et al. (1990) Ultrasonic evaluation of early carotid atherosclerosis. Stroke. 21:1567-72.
19. O'Leary DH et al. (1992) Distribution and correlates of sonographically detected carotid artery disease in the Cardiovascular Health Study. The CHS Collaborative Research Group. Stroke. 23: 1752-60.
20. Li R et al. (1994) B-mode-detected carotid artery plaque in a general population. Atherosclerosis Risk in Communities (ARIC) Study Investigators. Stroke. 25:2377-83.
21. Masuda M et al. (2003) Increase of soluble FcgRIIIa derived from natural killer cells and macrophages in plasma from patients with rheumatoid arthritis. J. Rheumatol. 30:1191-7.
22. Cheng KS, Mikhailidis DP, Hamilton G, Seifalian AM. (2002) A review of the carotid and femoral intima-media thickness as an indicator of the presence of peripheral vascular disease and cardiovascular risk factors. Cardiovasc. Res. 54: 528-38.
23. Plutzky J. (2001) Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am. J. Cardiol. 88:10K-15K.